AAV	adeno-associated virus
ADCs	antibody-Drug Conjugates
ADME	absorption, distribution, metabolism, and excretion
AOCs	antibody-oligonucleotide conjugates
ASGPR	sialoglycoprotein receptor
ASO	antisense oligonucleotide
BCR	B-cell receptor
CAR	chimeric antigen receptors
ChAd68	chimpanzee adenovirus
CLAN	cationic lipid-assisted nanoparticles
ctDNA	circulating tumor DNA
CTL	cytotoxic T lymphocytes
DBCO	dibenzoazacyclooctyne
DC	dendritic cell
EMA	European Medicines Agency
FDA	Food and Drug Administration
GalNAc	N-acetylgalactosamine
hATTR	hereditary transthyretin amyloidosis
HCC	hepatocellular carcinoma
HIV	human immunodeficiency virus
HO1	heme oxygenase-1
ICD	immunogenic cell death
ICIs	immune checkpoint inhibitors
IL-12	interleukin-12
LNPs	Lipid Nanoparticles
L-PPSN	polyethylenimine-modified porous silica nanoparticle
MARV	Marburg virus
MDSCs	Myeloid-derived suppressor cells
mRNA	messenger RNA
MSNs/MSNPs	mesoporous silica nanoparticles
MSS-CRC	microsatellite-stable colorectal cancer
PCL	poly(ε-caprolactone)
PD-L1	programmed cell death protein 1
PEG	polyethylene glycol
PEI	polyethyleneimine
PGs	poly(glycerols)
PHEMA	poly(2-hydroxyethyl methacrylate)
PHPMA	poly(hydroxypropyl methacrylate)
PLGA	poly(lactic-co-glycolic acid)
PMDA	Pharmaceuticals and Medical Devices Agency
PMO	morpholine oligonucleotide
POX	poly(oxazolines)
samRNA	self-amplifying RNA
siRNA	small interference RNA
SIV	simian immunodeficiency virus
SSNs	spiked silica nanoparticle
TAMs	tumor-associated macrophages
TCRs	T cell receptors
TDLN	tumor draining lymph node
TfR1	transferrin receptor 1
TLR	Toll-like receptors
TME	tumor microenvironment
TTR	transthyretin
VLP	virus-like particle